Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 5.


Andronis, L., Goranitis, I., Pirrie, S. et al. (19 more authors) (2016) Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747). BJU International. ISSN 1464-4096

James, N.D., Pirrie, S.J., Pope, A.M. et al. (19 more authors) (2016) Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both. JAMA Oncology, 2 (4). p. 493. ISSN 2374-2437

Gerrand, C.H., Billingham, L.J., Woll, P.J. et al. (1 more author) (2007) Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom. Sarcoma, 2007. 34128. ISSN 1357-714X

Ward, D.G., Suggett, N., Cheng, Y. et al. (7 more authors) (2006) Identification of serum biomarkers for colon cancer by proteomic analysis. BRITISH JOURNAL OF CANCER, 94 (12). pp. 1898-1905. ISSN 0007-0920

Ward, D.G., Cheng, Y., N'Kontchou, G. et al. (7 more authors) (2006) Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis. British Journal of Cancer, 94 (2). pp. 287-292. ISSN 0007-0920

This list was generated on Sun Oct 20 04:06:51 2019 BST.